Masimo held a 23.1% share of the US pulse oximetry systems market in 2025, as per GlobalData analysis.

Danaher Corporation (NYSE:DHR) announced it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ: ...

By Gnaneshwar Rajan and Christy Santhosh Feb 17 (Reuters) - Danaher will acquire Masimo in a $9.9 billion deal, as it looks ...

For those who like to run the numbers, Danaher claims it is paying “18x estimated 2027 EBITDA, or 15x 2027 estimated EBITDA ...

Danaher is buying Masimo for $180 per share in cash. Here why MASI could push DHR stock higher in 2026. Danaher shares are ...

Masimo Corporation agreed to be acquired by Danaher for $180/share, valuing MASI at $9.9B. Click here to read my most recent ...

A U.S. jury ordered Apple to pay Masimo $634 million in damages in the patent infringement case; Apple is appealing the decision. ・Masimo had a market capitalization of $7 billion on Friday. Med-tech ...

Masimo iSpO2 pulse oximeter and the iSpO2 app. Manufactured and submitted by Masimo Corp. (Irvine, CA). The iSpO2 is a measure-through-motion and low-perfusion pulse oximeter made for iPhone and iPad.

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 ...